Does Vascepa Have Patient Assistance Programs?
Vascepa (icosapent ethyl) is available through patient assistance programs for eligible patients. Amarin Pharma, the manufacturer, offers the Vascepa Savings Card, which provides significant copay assistance for commercially insured patients. Eligible individuals pay as little as $9 per month for up to 13 prescriptions per year, with a maximum annual benefit of $3,900 per patient. No income requirements apply, but patients must be 18+ and have coverage through commercial insurance; government insurance like Medicare or Medicaid disqualifies use.[1]
Uninsured or underinsured patients can access Vascepa for free through the Amarin CAREs patient assistance program. This covers a 90-day supply (240 capsules) shipped directly to U.S. patients meeting income guidelines—typically up to 400-500% of the federal poverty level, depending on household size—and lacking prescription coverage. Applications are submitted online or by phone, with approval often within days.[1][2]
Who Qualifies and How to Apply?
- Savings Card: Instant activation via the Vascepa website or pharmacy. Valid at most U.S. retail pharmacies; check eligibility at vascepa.com/savings.[1]
- Amarin CAREs: Requires proof of income, residency, and lack of insurance. Apply at caringforpatients.amarin.com or call 1-877-776-4335. Renewals needed every 12 months.[2]
Pharmacies like Costco or Walmart may also process these, but confirm with the provider.
What About Free Trial Offers or Coupons?
New patients can get a free 30- or 90-day trial supply through the Vascepa Starter Program, no assistance program needed—just a prescription and online enrollment. GoodRx coupons offer discounts up to 15-20% off retail (~$300/month without insurance), but they don't match manufacturer copay cards.[3]
How Does This Compare to Other Omega-3 Drugs?
Unlike Lovaza (also AbbVie), Vascepa's programs are more generous for high cholesterol patients on statins. Competitors like generic fish oils lack branded assistance, pushing patients toward over-the-counter options costing $20-50/month.
When Does Vascepa's Patent Coverage End?
Patents on Vascepa's formulation expire in 2036-2039, per DrugPatentWatch.com, delaying generics but not affecting current assistance programs.[4] No biosimilars yet due to its purified ethyl ester structure.
[1]: Vascepa.com/patient-savings - Official savings and CAREs details.
[2]: Amarin.com/caring-for-patients - CAREs application portal.
[3]: GoodRx.com/vascepa - Coupon pricing data.
[4]: DrugPatentWatch.com/p/icosapent-ethyl - Patent expiration timeline.